BK polyomavirus and valganciclovir: Highly suspected association urgently calling for a new randomized trial

. 2019 Dec ; 19 (12) : 3434-3435. [epub] 20191003

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu dopisy, práce podpořená grantem, komentáře

Perzistentní odkaz   https://www.medvik.cz/link/pmid31529778

Grantová podpora
CZ.02.1.01/0.0/0.0 European Regional Development Fund - International
LO1503 Ministry of Education, Youth and Sports of the Czech Republic - International
Q39 Charles University Research Fund - International

Odkazy

PubMed 31529778
DOI 10.1111/ajt.15598
PII: S1600-6135(22)09345-5
Knihovny.cz E-zdroje

Komentář

PubMed

Komentář

PubMed

Zobrazit více v PubMed

Reischig T, Kacer M, Hes O, et al. Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy. Am J Transplant. 2019;19(9):2457-2467.

Reischig T, Jindra P, Hes O, Svecova M, Klaboch J, Treska V. Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation. Am J Transplant. 2008;8(1):69-77.

Reischig T, Kacer M, Jindra P, Hes O, Lysak D, Bouda M. Randomized trial of valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation. Clin J Am Soc Nephrol. 2015;10(2):294-304.

Reischig T, Kacer M, Hruba P, et al. Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial. BMC Infect Dis. 2018;18(1):573.

Reischig T, Kacer M, Hes O, et al. Viral load and duration of BK polyomavirus viraemia determine renal graft fibrosis progression: histologic evaluation of late protocol biopsies [published online ahead of print 2019]. Nephrol Dial Transplant. https://doi.org/10.1093/ndt/gfz061.

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...